Article Text

AB0571 High Dose Intravenous Methylprednisolone Induces RAPID Improvement in Severe Ocular Inflammation. Multicenter Study of 104 Cases
  1. E. Beltrán-Catalán1,
  2. V. Calvo-Río2,
  3. R. Blanco-Alonso2,
  4. N. Ortego Centeno3,
  5. J.L. García Serrano4,
  6. L. Martinez-Costa Pérez5,
  7. A. Fonollosa Calduch6,
  8. M. Hernandez Garfella7,
  9. E. Valls8,
  10. F. Francisco Hernández9,
  11. M.A. Reyes10,
  12. I. Torre11,
  13. O. Maíz12,
  14. A. Blanco13,
  15. S. Muñoz-Fernández14,
  16. M.D.M. Esteban15,
  17. E. Pato-Cour16,
  18. M. Diaz17,
  19. R. Gallego17,
  20. M. Cordero-Coma18,
  21. F. Ortiz2,
  22. J. Cañal19,
  23. M.A. González-Gay2
  1. 1Servicio de Reumatología, Hospital General Universitario, Valencia
  2. 2Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander
  3. 3Unidad de Enfermedades Autoinmunes
  4. 4Servicio de Oftalmología, Hospital San Cecilio, Granada
  5. 5Servicio de Oftalmología, Hospital Dr. Peset, Valencia
  6. 6Servicio de Oftalmología, Hospital de Cruces, Bilbao
  7. 7Servicio de Oftalmología, Hospital General Universitario
  8. 8Servicio de Reumatología, Hospital Dr. Peset, Valencia
  9. 9Servicio de Reumatología
  10. 10Servicio de Oftalmología, Hospital Dr. Negrín, Gran Canaria
  11. 11Servicio de Reumatología, Hospital de Basurto, Bilbao
  12. 12Servicio de Reumatología, Hospital de Donostia, San Sebastian
  13. 13Servicio de Oftalmología, Hospital de Donostia, Bilbao
  14. 14Servicio de Reumatología
  15. 15Servicio de Oftalmología, Hospital Infanta Sofía
  16. 16Servicio de Reumatología, Hospital Clínico San Carlos, Madrid
  17. 17Servicio de Oftalmología, Hospital la Fe, Valencia
  18. 18Servicio de Oftalmología, Hospital de Leόn, Leόn
  19. 19Servicio de Oftalmología, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain


Background Intense ocular inflammation can cause an early and irreversible structural and functional damage.

Objectives Treatment with high-dose intravenous methylprednisolone (IVMP) can induce a rapid improvement in multiple inflammatory conditions including uveitis.

Methods A multicenter study of 104 patients (169 eyes) with severe ocular inflammation treated with IVMP attended in uveitis units of 11 hospitals. The most frequent underlying syndromes were: idiopathic uveitis (n=21), Vogt-Koyanagi-Harada (n=26), Behçet (n=19), spondyloarthritis (n=4), Sjögren syndrome (n=2), psoriatic arthritis (n=2) and multiple Sclerosis (n=2). The patients were evaluated at baseline and on days 2-5, 7, 15 and 30 after treatment with IVMP.

Results 104 patients (59 women/45 men) were studied with a mean age of 42.27±14.42 years (range 8-76 years) receiving doses of IVMP, which ranged from 0.25 to 1 gram per day for 2-5 consecutive days. They all had active and severe intraocular inflammation at baseline. The inflammatory ocular patterns were: panuveitis (n=61), posterior uveitis (n=35), anterior uveitis (n=3), scleritis (n=3) and intermediate uveitis (n=2). Bilateral ocular involvement was observed in 65 patients (62.5%). After IVMP treatment, the inflammation of the anterior chamber, the vitritis and visual acuity experienced rapid and statistically significant improvement from the second day. However, the improvement of retinal vasculitis, choroiditis/chorio-retinitis and macular edema was more slowly achieved, gaining statistical significance from the first week. Optical coherence tomography (OCT) showed a macular thickening (>250μ) in 90 eyes at baseline, with normalization in 30% of affected eyes at day 15 and in 50% of affected eyes at day 30 (p<0.05). IVMP therapy was well tolerated and no notable side effects were reported.

Conclusions Our study suggests that IVMP is an effective and safe remission induction therapy in severe ocular inflammation.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.4735

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.